Susana Puig
Head of the Dermatology ServiceResearch group
- Melanoma: imaging, genetics and immunology Group leader (R4)
Featured publications
-
Inherited MC1R variants in melanoma patients are associated with better survival in females
Authors: Lira FE, Podlipnik S, Potrony M, Tell-Martí G, Calbet-Llopart N, Barreiro A, Carrera C, Malvehy J, Puig S .Reference: British Journal Of Dermatology 2020. -
POT1 germline mutations but not TERT promoter mutations are implicated in melanoma susceptibility in a large cohort of Spanish melanoma families
Authors: Potrony M, Puig-Butille JA, Ribera-Sola M, Iyer V, Robles-Espinoza CD, Aguilera P, Carrera C, Malvehy J, Badenas C, Landi MT, Adams DJ, Puig S .Reference: British Journal Of Dermatology 2019. -
Adjuvant Pembrolizumab versus Placebo in Resected Stage III Melanoma.
Authors: Eggermont AMM, Blank CU, Mandala M, Long GV, Atkinson V, Dalle S, Haydon A, Lichinitser M, Khattak A, Carlino MS, Sandhu S, Larkin J, Puig S, Ascierto PA, Rutkowski P, Schadendorf D, Koornstra R, Hernandez-Aya L, Maio M, van den Eertwegh AJM, Grob JJ, Gutzmer R, Jamal R, Lorigan P, Ibrahim N, Marreaud S, van Akkooi ACJ, Suciu S, Robert C .Reference: New England Journal Of Medicine 2018. -
Melanocortin 1 receptor (MC1R) polymorphisms' influence on size and dermoscopic features of nevi.
Authors: Vallone MG, Tell-Marti G, Potrony M, Rebollo-Morell A, Badenas C, Puig-Butille JA, Gimenez-Xavier P, Carrera C, Malvehy J, Puig S .Reference: Pigment Cell & Melanoma Research 2018. -
IRF4 rs12203592 functional variant and melanoma survival.
Authors: Potrony M, Rebollo-Morell A, Giménez-Xavier P, Zimmer L, Puig-Butille JA, Tell-Marti G, Sucker A, Badenas C, Carrera C, Malvehy J, Schadendorf D, Puig S .Reference: International Journal Of Cancer 2017. -
Association Between Confocal Morphologic Classification and Clinical Phenotypes of Multiple Primary and Familial Melanomas
Authors: Grazziotin, Thais Corsetti; Alarcon, Ivette; Bonamigo, Renan Rangel; Carrera, Cristina; Potrony, Miriam; Aguilera, Paula; Puig-Butille, Joan-Anton; Brito, Johanna; Badenas, Celia; Alos, Llucia; Malvehy, Josep; Puig, Susana;.Reference: Jama Dermatology 2016. -
Performance of diagnostic tests in an intensive follow-up protocol for patients with American Joint Committee on Cancer (AJCC) stage IIB, IIC, and III localized primary melanoma: A prospective cohort study
Authors: Podlipnik S, Carrera C, Sánchez M, Arguis P, Olondo ML, Vilana R, Rull R, Vidal-Sicart S, Vilalta A, Conill C, Malvehy J, Puig S .Reference: Journal Of The American Academy Of Dermatology 2016. -
Characterization of individuals at high risk of developing melanoma in Latin America: bases for genetic counseling in melanoma
Authors: Puig S, Potrony M, Cuellar F, Puig-Butille JA, Carrera C, Aguilera P, Nagore E, Garcia-Casado Z, Requena C, Kumar R, Landman G, Costa Soares de Sá B, Gargantini Rezze G, Facure L, de Avila AL, Achatz MI, Carraro DM, Duprat Neto JP, Grazziotin TC, Bonamigo RR, Rey MC, Balestrini C, Morales E, Molgo M, Bakos RM, Ashton-Prolla P, Giugliani R, Larre Borges A, Barquet V, Pérez J, Martínez M, Cabo H, Cohen Sabban E, Latorre C, Carlos-Ortega B, Salas-Alanis JC, Gonzalez R, Olazaran Z, Malvehy J, Badenas C .Reference: Genetics In Medicine 2016. -
Prevalence of MITF p.E318K in Patients With Melanoma Independent of the Presence of CDKN2A Causative Mutations
Authors: Potrony, Miriam; Puig-Butille, Joan Anton; Aguilera, Paula; Badenas, Celia; Tell-Marti, Gemma; Carrera, Cristina; Javier del Pozo, Luis; Conejo-Mir, Julian; Malvehy, Josep; Puig, Susana;.Reference: Jama Dermatology 2016.
Featured Projects
-
Implicación del perfil inmunológico específico cutáneo determinado en sangre periférica en el pronóstico y respuesta a tratamiento del melanoma
Principal investigator: Susana PuigFunder: Institut d`Investigacions Biomèdiques August Pi i Sunyer (Sede); Instituto de Salud Carlos IIICode: PI18/00419Duration: 02/01/2019 - 31/12/2021 -
Evaluación de las alteraciones inmunológicas subyacentes en el desarrollo, progresión y respuesta a las terapias inmunológicas en melanoma. Implicación de la microbiota en la inducción de tolerancia y efectos secundarios de las terapias inmunológicas.
Principal investigator: Puig SFunder: CONSORCI INSTITUT D'INVESTIGACIONS BIOMEDIQUES AUGUST PI I SUNYER (Sede); Institut d`Investigacions Biomèdiques August Pi i Sunyer (Sede); Instituto de Salud Carlos IIICode: PI15/00716Duration: 01/01/2016 - 31/12/2018 -
Vías de diseminación mestastásica en distintos subtipos del melanoma maligno: nuevos biomarcadores tumorales y dianas terapeuticas.
Principal investigator: Susana Puig SardaFunder: CONSORCI INSTITUT D'INVESTIGACIONS BIOMEDIQUES AUGUST PI I SUNYER (Sede); Asociación Española Contra el CáncerCode: GCB15152978SOENDuration: 01/01/2015 - 01/01/2020 -
DIAGNOPTICS- Diagnosis of skin cancer using optics
Principal investigator: Susana Puig SardaFunder: CONSORCI INSTITUT D'INVESTIGACIONS BIOMEDIQUES AUGUST PI I SUNYER (Sede); Comisión EuropeaDuration: 01/01/2013 - 01/01/2016 -
Implementation of personalized medicine in cutaneous melanoma based on genomic susceptibility and tumor signatures: Identification of new targets for melanoma treatment.
Principal investigator: Marti R, Susana Puig SardaCode: 20133130Duration: 01/01/2014 - 31/12/2017